Skip to main content
Equibles
ORGO logo

ORGO · Organogenesis Holdings Inc.

Track ORGO — free

Use ORGO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.64 -0.03 (-1.80%)
Russell 2000 member Rebalance outlook locked
Market Cap
$209.74M
Shares
128.67M

ORGO metrics

75 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.67
Market cap
$209.74M

Price action

19 metrics
Price change (1W)
-4.6%
Price change (30D)
-29.5%
Price change (3M)
-28.3%
Price change (6M)
-41.8%
Price change (YTD)
-67.8%
Price change (1Y)
-65.9%
Trailing year
Price change (5Y)
-90.0%
52-week high
$6.54
52-week low
$1.63
Change from 52-week high
-74.5%
Change from 52-week low
+2.5%
Annualized volatility
77.4%
Beta
1.3
RSI (14D)
34.2
Price vs SMA 50
-24.0%
Price vs SMA 200
-46.9%
Avg volume (3M)
809,137
Relative volume
1.2
Average dollar volume
$1.79M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
128.67M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 218.1%
P / book
1.4
reciprocal yield 70.7%
FCF yield
9.9%
TTM · current market cap
Buyback yield
—
P / FCF
10.1
reciprocal yield 9.9%
P / operating cash flow
6.6
reciprocal yield 15.2%
Earnings yield
-40.1%

Historical valuation

8 metrics
P / E historical average (3Y)
38.7×
reciprocal yield 2.6%
P / E historical average (5Y)
27.9×
reciprocal yield 3.6%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 111.0%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 54.5%
EV / EBIT historical average (3Y)
19.5×
reciprocal yield 5.1%
EV / EBIT historical average (5Y)
30.9×
reciprocal yield 3.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-7.8%
Trailing 12 months
Net margin
-18.4%
Gross profit (TTM)
$347.99M
Operating profit (TTM)
−$35.87M
Net income (TTM)
−$84.16M
Trailing 12 months
Diluted EPS (TTM)
$-0.79
FCF margin
4.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.23

Growth

11 metrics
Revenue growth YoY
-56.7%
Year over year
Net income growth YoY
+4,201.0%
Revenue (TTM)
$457.45M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.4%
Year over year · more shares
Revenue CAGR (3Y)
+7.8%
Revenue CAGR (5Y)
+10.8%
EPS CAGR (3Y)
+7.7%
EPS CAGR (5Y)
+0.0%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-56.8%
Return on assets
-20.7%
Debt / equity
—
Current ratio
3.5
EBITDA (TTM)
−$19.93M
Free cash flow (TTM)
$20.84M
Quick ratio
3.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$46.10M
Total assets
$406.45M
Total debt
$62.34M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$31.97M
Capital expenditures (TTM)
$11.13M
R&D (TTM)
$56.97M
SG&A (TTM)
$299.07M
Stock compensation (TTM)
$14.08M
R&D / revenue
12.5%
Stock compensation / revenue
3.1%

Ownership (13F)

3 metrics
13F filers
135
13F filer change QoQ
+14
Institutional ownership
51.3%

Short interest

3 metrics
Short interest
11.1%
Latest settlement · 11.7 days to cover
Days to cover
11.7d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1661181 CUSIP 68621F102 13F (30d) 110 filings 110 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)